Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cyclin-dependent kinase inhibitors identified by Bristol-Myers Squibb

Aug. 9, 2001

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Aug. 9, 2001

Ascorbic acid enhances arsenic trioxide potency in MM cells

Aug. 9, 2001

Arizona State University scientists design new DNA reductive alkylating agents

Aug. 8, 2001

Rigel and Novartis begin collaboration to discover antiangiogenic agents

Aug. 8, 2001

Cell Genesys expands oncology pipeline with acquisition of Calydon

Aug. 8, 2001

Benzyl tetralins reported to have potential in treating androgen- or estrogen-mediated diseases

Aug. 7, 2001

Vion initiates phase II clinical trials of Triapine for metastatic breast cancer

Aug. 7, 2001

Cell Pathways begins phase II trials of CP-461 in several types of cancer

Aug. 7, 2001

NCI awards Phase I SBIR grant to Kosan Biosciences for anticancer compound

Aug. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...